JD Supra2d
FDA Finalizes Two Food Allergen-Related Guidance Documents
FDA published two final guidance documents related to food allergens: Questions and Answers Regarding Food Allergens, ...
JD Supra8d
FDA Releases Proposed Front-of-Package Nutrition Labeling Rule
On January 16, 2025, the U.S. Food and Drug Administration (“FDA”) published a highly anticipated proposed rule on front-of-package (“FOP”) ...
Beverage15d
New US alcohol labeling rules proposed
The proposals would see alcohol labeling come closer to that for non-alcoholic beverages: with serving sizes, calorie counts, ...
Heartland21d
What the FDA Gets Wrong About Drug Ads – Commentary
Drug companies in the U.S. are spending $4 billion a year on TV ads touting the drug benefits with rapid-fire list of ...
Medscape6d
Introduction to the New Prescription Drug Labeling by the Food and Drug Administration
The revised prescription drug labeling developed by the Food and Drug Administration (FDA) is described. Summary: A new FDA final rule, "Requirements on Content and Format of Labeling for Human ...
Agri-Pulse22d
FDA proposes front-of-pack labeling ahead of administration shift
The Food and Drug Administration has proposed its long-awaited front-of-pack labeling rule ... the proposal would not change existing regulations that allow food manufacturers to voluntarily ...
Rolling Out9d
FDA bans red dye but 8 risky food colors remain legal
Discover what FDA's red dye ban means for your food safety. Learn which synthetic colors remain in your favorite foods and ...
CNN21d
FDA bans red dye No. 3 from food, drinks and ingested drugs in the US
The US Food and Drug Administration has banned the use of ... look for dyes in the “inactive ingredients” section of the drug labeling or package insert, or search for dye-free versions ...
FDA’s Red Dye No. 3 Ban, Explained—What It Means For Food And Trust
For decades, FD&C Red No. 3 has added its vivid cherry-red hue to candies and cupcakes—but its risks have been debated just as long.
Becker's Hospital Review6d
FDA warns GLP-1 compounder over safety rules
The FDA issued a warning letter to ProRx, a compounding facility in Exton, Penn., after an inspection raised serious concerns regarding the safety and compliance of its drug products. The facility, ...